Maine Passes 340B Contract Pharmacy Access Bill with Added Hospital Reporting Requirements, Sends to Governor

The Maine Legislature passed a 340B contract pharmacy access bill with added hospital reporting requirements on June 16.
Maine lawmakers yesterday passed a 340B contract pharmacy access bill that adds new hospital reporting requirements on top of an [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Why a Health Insurance Crisis Led Vermont Lawmakers to Add Hospital Price Caps to a 340B Contract Pharmacy Access Law

Vermont legislators added hospital price caps to a 340B contract pharmacy access law amid a financial crisis facing the state's largest health insurer.
When Vermont enacted a 340B contract pharmacy access law last week, it also became the first state in the nation [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Oregon Providers Applaud Passage of 340B Contract Pharmacy Access Law

Oregon Gov. Tina Kotek (D) on June 11 signed into law a 340B contract pharmacy bill that has strong backing from state providers.
Oregon 340B providers are applauding the state’s new law prohibiting drugmakers from placing 340B contract pharmacy restrictions in the state. [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Major North Carolina Health System Sues Aetna, Humana for Alleged 340B Underpayment

UNC Health recently sued Aetna and Humana in a federal district court for allegedly underpaying hospitals for 340B drugs.
A major North Carolina health system has sued insurers Aetna Health and Humana for allegedly underpaying for 340B drugs purchased [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Vermont, Oregon Enact 340B Contract Pharmacy Access Laws; Vermont Measure Includes Controversial Hospital Price Caps

Vermont Gov. Phil Scott (R) and Oregon Gov. Tina Kotek (D) each signed 340B legislation in their states on June 11.
Vermont and Oregon yesterday became the latest states to enact 340B contract pharmacy access laws, with Vermont’s new statute also [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Federal Appellate Court Fast-Tracks Drugmakers’ Appeal of 340B Rebate Ruling

A federal appellate court in Washington, D.C. will hear two drugmakers' appeal of a lower courts 340B rebate ruling on an expedited schedule.
A federal appellate court in Washington, D.C. is fast-tracking Novartis and Bristol Myers Squibb’s (BMS) appeal of a lower court [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

CMS Offers New Details on Medicare Drug Price Negotiations, 340B Advocates Raise Concerns About Impact on Program

340B stakeholders raised concerns about May 12 draft guidance on the IRA Medicare Drug Price Negotiation Program's “manufacturer effectuation of the maximum fair price in 2026, 2027 and 2028,” among other things.
The Centers for Medicare and Medicaid Services (CMS) released new details this week to help stakeholders navigate the Inflation Reduction [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Leading 340B and Pharmacy Solutions Firm Maxor Rebrands as ‘VytlOne’

Kim Tzoumakas, CEO of VytlOne (formerly Maxor), said the company's rebrand "exemplifies our unique position as a full-service pharmacy management partner."
Maxor, a leading integrated pharmacy services and 340B solutions provider first established nearly 100 years ago in a small Texas [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

How Oklahoma Lawmakers Defied Their Governor and Fought Dark Money to Enact a 340B Contract Pharmacy Access Law

Oklahoma state lawmakers overrode their governor's veto to enact a 340B contract pharmacy access law despite strong opposition from dark money groups and conservative influencers.
In the final hour of Oklahoma’s 2025 legislative session, as the clock neared 11 p.m. on May 29, state legislators [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Drug-Industry Funded Study Finds Utilization Drives 340B Program Growth, Not Rising Drug Prices

A recent drug-industry funded study in Health Affairs Scholar found that increased utilization, rather than rising drug prices, drives 340B program growth.
A recent drug-industry-funded study attributes the 340B program’s recent growth to increased utilization—not rising drug prices. The May 21 study, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live